1. Home
  2. Analysis
  3. Irbesartan
  4. Fentanyl-100

Irbesartan and Fentanyl-100 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Irbesartan and Fentanyl-100 together.

The phase IV clinical study analyzes what interactions people who take Irbesartan and Fentanyl-100 have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

4 people who take Irbesartan and Fentanyl-100 together, and have interactions are studied.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 29,915 Irbesartan users for its effectiveness, alternative drugs and more.

What is Fentanyl-100?

Fentanyl-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 7,047 Fentanyl-100 users for its effectiveness, alternative drugs and more.

Number of Irbesartan and Fentanyl-100 reports submitted per year:

Irbesartan and Fentanyl-100 drug interactions.

Common Irbesartan and Fentanyl-100 drug interactions by gender *:

female:

  1. Atelectasis
  2. Bronchospasm
  3. Dysarthria
  4. Monoparesis
  5. Wheezing

male:

  1. Acute myocardial infarction
  2. Acute pulmonary oedema
  3. Cerebral atrophy
  4. Cerebral ischaemia
  5. Chronic obstructive pulmonary disease
  6. Colitis
  7. Confusional state
  8. Deafness neurosensory
  9. Dementia
  10. Dyspepsia

Common Irbesartan and Fentanyl-100 drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Atelectasis
  2. Bronchospasm
  3. Dysarthria
  4. Monoparesis
  5. Wheezing

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Acute myocardial infarction
  2. Acute pulmonary oedema
  3. Cerebral atrophy
  4. Cerebral ischaemia
  5. Chronic obstructive pulmonary disease
  6. Colitis
  7. Confusional state
  8. Deafness neurosensory
  9. Dementia
  10. Dyspepsia

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Fentanyl-100?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Irbesartan and Fentanyl-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Irbesartan side effects:

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fentanyl-100 side effects:

Browse all side effects of Fentanyl-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Irbesartan interactions:

Browse all interactions between Irbesartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fentanyl-100 interactions:

Browse all interactions between Fentanyl-100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan and fentanyl (the active ingredients of Irbesartan and Fentanyl-100, respectively), and Irbesartan and Fentanyl-100 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Irbesartan and Fentanyl-100.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.